Alan Brox

730 total citations
19 papers, 532 citations indexed

About

Alan Brox is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alan Brox has authored 19 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Genetics and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alan Brox's work include Erythrocyte Function and Pathophysiology (4 papers), Erythropoietin and Anemia Treatment (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Alan Brox is often cited by papers focused on Erythrocyte Function and Pathophysiology (4 papers), Erythropoietin and Anemia Treatment (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Alan Brox collaborates with scholars based in Canada, Switzerland and Belgium. Alan Brox's co-authors include Raymonde F. Gagnon, Hugh G. Robson, A. Peter H. McLean, Vivian G. Loo, Chaim Shustik, Kang Howson‐Jan, Axel A. Fauser, Gerald J. Berry, Céline Bertrand and Marion Sternbach and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Kidney International and The American Journal of Medicine.

In The Last Decade

Alan Brox

19 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Brox Canada 13 198 120 117 91 88 19 532
Salvatore Perrone Italy 14 132 0.7× 69 0.6× 36 0.3× 99 1.1× 70 0.8× 60 598
Leyla Ağaoğlu Türkiye 15 465 2.3× 349 2.9× 57 0.5× 91 1.0× 78 0.9× 46 883
T. C. M. Morris United Kingdom 13 152 0.8× 189 1.6× 27 0.2× 123 1.4× 57 0.6× 40 530
Deniz Aslan Türkiye 14 338 1.7× 132 1.1× 84 0.7× 145 1.6× 132 1.5× 50 707
Stebbins B. Chandor United States 17 95 0.5× 74 0.6× 76 0.6× 79 0.9× 135 1.5× 36 654
Renée V. Gardner United States 16 311 1.6× 220 1.8× 42 0.4× 124 1.4× 22 0.3× 45 663
N.P. Lucie United Kingdom 15 160 0.8× 91 0.8× 26 0.2× 119 1.3× 85 1.0× 43 513
Han Joo Baek South Korea 17 180 0.9× 38 0.3× 87 0.7× 50 0.5× 120 1.4× 68 997
Tapio Nousiainen Finland 17 203 1.0× 67 0.6× 26 0.2× 251 2.8× 167 1.9× 32 647
A Concannon Australia 16 446 2.3× 93 0.8× 56 0.5× 171 1.9× 133 1.5× 45 816

Countries citing papers authored by Alan Brox

Since Specialization
Citations

This map shows the geographic impact of Alan Brox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Brox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Brox more than expected).

Fields of papers citing papers by Alan Brox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Brox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Brox. The network helps show where Alan Brox may publish in the future.

Co-authorship network of co-authors of Alan Brox

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Brox. A scholar is included among the top collaborators of Alan Brox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Brox. Alan Brox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Brox, Alan, et al.. (1998). ERYTHROCYTOSIS AFTER RENAL TRANSPLANTATION REPRESENTS AN ABNORMALITY OF INSULIN-LIKE GROWTH FACTOR-I AND ITS BINDING PROTEINS1. Transplantation. 66(8). 1053–1058. 32 indexed citations
2.
Brox, Alan, et al.. (1998). Successful treatment of acquired factor VIII inhibitors with cyclosporin. American Journal of Hematology. 57(1). 87–88. 30 indexed citations
3.
Brox, Alan, et al.. (1998). Successful treatment of acquired factor VIII inhibitors with cyclosporin. American Journal of Hematology. 57(1). 87–88. 2 indexed citations
4.
Zhang, F., et al.. (1996). Anemia of Chronic Renal Failure: Characterization in the Mouse and Correction with Human Recombinant Erythropoietin. ˜The œNephron journals/Nephron journals. 72(4). 654–661. 13 indexed citations
5.
Loo, Vivian G., et al.. (1996). Control of Construction-Associated Nosocomial Aspergillosis in an Antiquated Hematology Unit. Infection Control and Hospital Epidemiology. 17(6). 360–364. 108 indexed citations
6.
Brox, Alan, et al.. (1996). Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse. Kidney International. 50(3). 937–943. 34 indexed citations
7.
Laneuville, Pierre, et al.. (1996). Effect of chronic renal failure on the expression of erythropoietin message in a murine model.. PubMed. 24(13). 1469–74. 19 indexed citations
8.
Loo, Vivian G., et al.. (1996). Control of Construction-Associated Nosocomial Aspergillosis in an Antiquated Hematology Unit. Infection Control and Hospital Epidemiology. 17(6). 360–364. 54 indexed citations
9.
Cheung, Wing K., Lane J. Brunner, Steve Schoenfeld, et al.. (1994). PHARMACOKINETICS OF PAMIDRONATE DISODIUM IN CANCER PATIENTS AFTER A SINGLE INTRAVENOUS INFUSION OF 30-, 60− OR 90-mg DOSE OVER 4 OR 24 HOURS. American Journal of Therapeutics. 1(3). 228–235. 6 indexed citations
10.
Chan, Keith K. H., et al.. (1993). Urinary Excretion of Aminohydroxypropylidene Bisphosphonate in Cancer Patients after Single Intravenous Infusions. Journal of Pharmaceutical Sciences. 82(6). 665–667. 8 indexed citations
11.
Brox, Alan & Chaim Shustik. (1993). Non-Hodgkin's Lymphoma of the Spleen. Leukemia & lymphoma. 11(3-4). 165–171. 36 indexed citations
12.
Congote, L.F., Alan Brox, F K Lin, Hsienwie Lu, & AA Fauser. (1991). THE N-TERMINAL SEQUENCE OF THE MAJOR ERYTHROPOIETIC FACTOR OF AN ANEPHRIC PATIENT IS IDENTICAL TO INSULIN-LIKE GROWTH FACTOR I.. The Journal of Clinical Endocrinology & Metabolism. 72(3). 727–729. 22 indexed citations
13.
Brox, Alan, et al.. (1991). Primary non‐Hodgkin lymphoma of the spleen. American Journal of Hematology. 38(2). 95–100. 45 indexed citations
14.
Boonen, Steven, et al.. (1990). ASCORBATE FOR THE TREATMENT OF REFRACTORY IDIOPATHIC THKOMBOCYTOPENIC PIJRPURA. British Journal of Haematology. 74(2). 234–235. 8 indexed citations
15.
Brox, Alan, Kang Howson‐Jan, & Axel A. Fauser. (1988). Treatment of idiopathic thrombocytopenic purpura with ascorbate. British Journal of Haematology. 70(3). 341–344. 44 indexed citations
16.
Brox, Alan, et al.. (1987). Hemolytic anemia following intravenous gamma globulin administration. The American Journal of Medicine. 82(3). 633–635. 52 indexed citations
17.
Brox, Alan, et al.. (1986). Expression of common acute lymphoblastic leukemia-associated antigen on germ cell tumor. The American Journal of Medicine. 80(6). 1249–1252. 13 indexed citations
18.
Brox, Alan, Gerald B. Price, & Arthur K. Sullivan. (1985). An antigen related to the phenotype of multi-drug resistance can be induced in vivo and used as a target for immunotherapy of rat leukemia. Leukemia Research. 9(8). 987–992. 2 indexed citations
19.
Brox, Alan, Simone A. Glynn, & Arthur K. Sullivan. (1984). Blastic variants of rat promyelocytic leukemia produce neurologic disease. Leukemia Research. 8(1). 81–86. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvatore Perrone Breakdown of academic impact, for papers by Leyla Ağaoğlu Breakdown of academic impact, for papers by T. C. M. Morris Breakdown of academic impact, for papers by Deniz Aslan Breakdown of academic impact, for papers by Stebbins B. Chandor Breakdown of academic impact, for papers by Renée V. Gardner Breakdown of academic impact, for papers by N.P. Lucie Breakdown of academic impact, for papers by Han Joo Baek Breakdown of academic impact, for papers by Tapio Nousiainen Breakdown of academic impact, for papers by A Concannon
Rankless by CCL
2026